论文部分内容阅读
目的评价经内镜逆行胰胆管造影(ERCP)结合胰胆管腔内超声(IDUS)对胰腺癌的诊断价值。方法回顾性分析解放军总医院2001年1月至2006年7月收治的胰腺癌患者127例,其中113例行ERCP检查,113例中16例行IDUS检查,并与122例体表B超(B-US)检查结果对照。结果ERCP的诊断准确率为92.0%(104/113),IDUS为100%(16/16),B-US为81.1%(99/122),ERCP结合IDUS为99.1%(112/113)。ERCP诊断胰腺癌的准确率显著高于B-US,ERCP结合IDUS的诊断准确率明显高于ERCP及B-US(均P<0.05)。结论ERCP在胰腺癌诊断中有重要价值,必要时结合IDUS可以进一步提高诊断的准确性。
Objective To evaluate the diagnostic value of endoscopic retrograde cholangiopancreatography (ERCP) and pancreaticoduodenectomy (IDUS) for pancreatic cancer. Methods A total of 127 patients with pancreatic cancer admitted to PLA General Hospital from January 2001 to July 2006 were retrospectively analyzed. Among them, 113 were ERCP and 16 of 113 were IDUS. -US) check the results of the control. Results The diagnostic accuracy of ERCP was 92.0% (104/113), IDUS was 100% (16/16), B-US was 81.1% (99/122), ERCP binding IDUS was 99.1% (112/113). The accuracy of ERCP in diagnosing pancreatic cancer was significantly higher than that of B-US. The diagnostic accuracy of ERCP combined with IDUS was significantly higher than that of ERCP and B-US (all P <0.05). Conclusions ERCP is of great value in the diagnosis of pancreatic cancer. If necessary, the combination of IDUS can further improve the diagnostic accuracy.